Medicinal Products

CellCept

The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.

Name CellCept
Active Substance mofetilmikofenolat
Prescription na recept
Type of prescription ograničeni recept (tvrda kapsula, prašak za koncentrat za otopinu za infuziju, prašak za oralnu suspenziju, tableta)
Distribution u ljekarni
ATC Code L04AA06
Medicinal product marketed in the Croatia Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL) download
Link to the European Medicines Agency's (EMA) product information download
Link to the European Commission's (EC) decisions download
Educational materials
for healthcare professionals
Upitnik za zdravstvene radnike, verzija 1
Obrazac za prijavu i praćenje trudnoće za zdravstvene radnike, verzija 1
Vodič za zdravstvene radnike, verzija 2
Educational materials
for patients / caregivers
Vodič za bolesnike, verzija 2
Upitnik za bolesnike, verzija 1

Direct Healthcare Professional Communication

Name Date Download
Pismo zdravstvenim radnicima o izmijenjenim preporukama za kontracepciju povezanim s primjenom mofetilmikofenolata/mikofenolatne kiseline (CellCept, Myfortic, Trixin) 22.01.2018 Roche d.o.o., Novartis Hrvatska d.o.o., Pliva Hrvatska d.o.o.
Back